Report Detail

Other Global and China K Cells Market Size, Status and Forecast 2020-2026

  • RnM4203659
  • |
  • 14 September, 2020
  • |
  • Global
  • |
  • 94 Pages
  • |
  • QYResearch
  • |
  • Other

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global K Cells Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Mogamulizumab
    • 1.2.3 Lorvotuzumab Mertansine
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global K Cells Market Share by Application: 2020 VS 2026
    • 1.3.2 Cancer
    • 1.3.3 Cardiovascular Diseases
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global K Cells Market Perspective (2015-2026)
  • 2.2 Global K Cells Growth Trends by Regions
    • 2.2.1 K Cells Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 K Cells Historic Market Share by Regions (2015-2020)
    • 2.2.3 K Cells Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top K Cells Players by Market Size
    • 3.1.1 Global Top K Cells Players by Revenue (2015-2020)
    • 3.1.2 Global K Cells Revenue Market Share by Players (2015-2020)
  • 3.2 Global K Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by K Cells Revenue
  • 3.4 Global K Cells Market Concentration Ratio
    • 3.4.1 Global K Cells Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by K Cells Revenue in 2019
  • 3.5 Key Players K Cells Area Served
  • 3.6 Key Players K Cells Product Solution and Service
  • 3.7 Date of Enter into K Cells Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 K Cells Breakdown Data by Type (2015-2026)

  • 4.1 Global K Cells Historic Market Size by Type (2015-2020)
  • 4.2 Global K Cells Forecasted Market Size by Type (2021-2026)

5 K Cells Breakdown Data by Application (2015-2026)

  • 5.1 Global K Cells Historic Market Size by Application (2015-2020)
  • 5.2 Global K Cells Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America K Cells Market Size (2015-2026)
  • 6.2 North America K Cells Market Size by Type (2015-2020)
  • 6.3 North America K Cells Market Size by Application (2015-2020)
  • 6.4 North America K Cells Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe K Cells Market Size (2015-2026)
  • 7.2 Europe K Cells Market Size by Type (2015-2020)
  • 7.3 Europe K Cells Market Size by Application (2015-2020)
  • 7.4 Europe K Cells Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China K Cells Market Size (2015-2026)
  • 8.2 China K Cells Market Size by Type (2015-2020)
  • 8.3 China K Cells Market Size by Application (2015-2020)
  • 8.4 China K Cells Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan K Cells Market Size (2015-2026)
  • 9.2 Japan K Cells Market Size by Type (2015-2020)
  • 9.3 Japan K Cells Market Size by Application (2015-2020)
  • 9.4 Japan K Cells Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia K Cells Market Size (2015-2026)
  • 10.2 Southeast Asia K Cells Market Size by Type (2015-2020)
  • 10.3 Southeast Asia K Cells Market Size by Application (2015-2020)
  • 10.4 Southeast Asia K Cells Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Takeda Pharmaceutical (Japan)
    • 11.1.1 Takeda Pharmaceutical (Japan) Company Details
    • 11.1.2 Takeda Pharmaceutical (Japan) Business Overview
    • 11.1.3 Takeda Pharmaceutical (Japan) K Cells Introduction
    • 11.1.4 Takeda Pharmaceutical (Japan) Revenue in K Cells Business (2015-2020))
    • 11.1.5 Takeda Pharmaceutical (Japan) Recent Development
  • 11.2 Sorrento Therapeutics Inc. (USA)
    • 11.2.1 Sorrento Therapeutics Inc. (USA) Company Details
    • 11.2.2 Sorrento Therapeutics Inc. (USA) Business Overview
    • 11.2.3 Sorrento Therapeutics Inc. (USA) K Cells Introduction
    • 11.2.4 Sorrento Therapeutics Inc. (USA) Revenue in K Cells Business (2015-2020)
    • 11.2.5 Sorrento Therapeutics Inc. (USA) Recent Development
  • 11.3 NantKwest Inc. (USA)
    • 11.3.1 NantKwest Inc. (USA) Company Details
    • 11.3.2 NantKwest Inc. (USA) Business Overview
    • 11.3.3 NantKwest Inc. (USA) K Cells Introduction
    • 11.3.4 NantKwest Inc. (USA) Revenue in K Cells Business (2015-2020)
    • 11.3.5 NantKwest Inc. (USA) Recent Development
  • 11.4 Bristol-Myers Squibb (USA)
    • 11.4.1 Bristol-Myers Squibb (USA) Company Details
    • 11.4.2 Bristol-Myers Squibb (USA) Business Overview
    • 11.4.3 Bristol-Myers Squibb (USA) K Cells Introduction
    • 11.4.4 Bristol-Myers Squibb (USA) Revenue in K Cells Business (2015-2020)
    • 11.4.5 Bristol-Myers Squibb (USA) Recent Development
  • 11.5 NKT Therapeutics (USA)
    • 11.5.1 NKT Therapeutics (USA) Company Details
    • 11.5.2 NKT Therapeutics (USA) Business Overview
    • 11.5.3 NKT Therapeutics (USA) K Cells Introduction
    • 11.5.4 NKT Therapeutics (USA) Revenue in K Cells Business (2015-2020)
    • 11.5.5 NKT Therapeutics (USA) Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global K Cells Scope and Market Size
    K Cells market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global K Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Mogamulizumab
    Lorvotuzumab Mertansine
    Others

    Market segment by Application, split into
    Cancer
    Cardiovascular Diseases
    Others

    Based on regional and country-level analysis, the K Cells market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global K Cells market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Takeda Pharmaceutical (Japan)
    Sorrento Therapeutics Inc. (USA)
    NantKwest Inc. (USA)
    Bristol-Myers Squibb (USA)
    NKT Therapeutics (USA)
    ...


    Summary:
    Get latest Market Research Reports on K Cells. Industry analysis & Market Report on K Cells is a syndicated market report, published as Global and China K Cells Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of K Cells market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,048.88
    4,573.33
    6,097.77
    3,324.31
    4,986.46
    6,648.62
    408,201.30
    612,301.95
    816,402.60
    286,600.47
    429,900.71
    573,200.94
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report